Who we are
and the problems
we solve ...

Today’s skincare market is aiming to develop and provide efficient treatment solutions for more than 3,000 skin diseases. Driven by this challenge, combined with the high medical need, a multitude of new or improved formulas are under constant development and get released each year into a fast growing and highly diverse global Dermatology market.

Despite of the fact that there are tremendous international R&D activities in Biopharma, Cosmetics, and Medical industry there is an extreme lack of objective technologies for easy detecting, monitoring and analysis of the investigated skin issues and for validating safety and efficacy of the tested treatment options. The visual assessment of skin disorders is limited in precision and can be highly time-consuming, often leading to weak information and results, especially when the study size or observed effects are small.

In the end, inefficient procedures costs healthcare providers a lot of time and money and can lower also the change of a treatment success. Thus novel and state of the art digital solutions for global health care industry and patients are required.

Management Board

Advisory Board

Our interdisciplinary team delivers state of the art digital solutions closing technology gaps in Dermatology and Telemedicine

The clinically validated software platform Scarletred® is on market since 2015 and enables high quality remote skin imaging and analysis in a multitude of skin conditions. Our first product and award winning technology is supplied internationally via flexible Software as a Service (SaaS) to Biopharma, Cosmetics and Medtech companies. The platform has been extended in 2020 by new Telemedicine SaaS tools for governmental, hospital and medical routine use.